- Report
- January 2026
- 180 Pages
Global
From €4137EUR$4,500USD£3,517GBP
- Report
- September 2026
- 195 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- October 2026
- 281 Pages
Global
From €5378EUR$5,850USD£4,572GBP
- Report
- July 2026
- 120 Pages
Global
From €4366EUR$4,750USD£3,712GBP
- Report
- November 2025
- 145 Pages
Global
From €3631EUR$3,950USD£3,087GBP
- Report
- August 2026
- 160 Pages
Global
From €3052EUR$3,320USD£2,595GBP
€3815EUR$4,150USD£3,243GBP
- Report
- January 2026
- 307 Pages
Global
From €4137EUR$4,500USD£3,517GBP
- Report
- July 2026
- 250 Pages
Global
From €4127EUR$4,490USD£3,509GBP
- Report
- December 2025
- 481 Pages
Global
From €4411EUR$4,799USD£3,751GBP
- Report
- September 2026
- 191 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 183 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- July 2026
- 170 Pages
Global
From €4366EUR$4,750USD£3,712GBP
- Report
- October 2026
- 381 Pages
Global
From €5378EUR$5,850USD£4,572GBP
- Report
- October 2026
- 255 Pages
Global
From €5378EUR$5,850USD£4,572GBP
- Report
- August 2026
- 120 Pages
Global
From €4366EUR$4,750USD£3,712GBP
- Report
- July 2026
- 111 Pages
Global
From €4366EUR$4,750USD£3,712GBP
- Report
- July 2026
- 160 Pages
Global
From €3052EUR$3,320USD£2,595GBP
€3815EUR$4,150USD£3,243GBP
- Report
- February 2026
- 160 Pages
Global
From €3052EUR$3,320USD£2,595GBP
€3815EUR$4,150USD£3,243GBP
- Report
- August 2025
- 495 Pages
Global
From €4550EUR$4,950USD£3,869GBP
- Report
- April 2023
- 301 Pages
Global
From €4550EUR$4,950USD£3,869GBP

Bioburden is a term used in biotechnology to refer to the number of viable microorganisms present in a sample. It is an important factor in the production of biopharmaceuticals, medical devices, and other products. Bioburden testing is used to ensure that products are free from contamination and to monitor the quality of the manufacturing process. The bioburden market is composed of companies that provide testing services, equipment, and consumables. These companies offer a range of products and services, including microbial identification, enumeration, and detection.
The bioburden market is highly competitive, with a number of established players and new entrants. Companies in the market include 3M, Merck, Thermo Fisher Scientific, Bio-Rad, and Charles River Laboratories. Show Less Read more